
Lee Jung-jae and his agency, Artist Company, where he serves as the largest shareholder, have strongly denied allegations of receiving preferential settlement treatment.
On November 18, Artist Company released an official statement addressing reports by Dispatch, stating that although the agency provided detailed explanations regarding the structure of actor settlement contracts, the background of headquarters relocation, rental fee calculation grounds, the economic substance of the Vena Beauty contract, and other business reorganization backgrounds, the resulting article only formally cited parts of the explanation while omitting crucial comparative facts and objective grounds.
The agency expressed deep regret over the report, stating that the profit distribution upper limit is not a special privilege exclusively granted to actor Lee Jung-jae. They explained that another fellow actor who served as an internal director alongside Lee Jung-jae did not receive a separate executive salary either, and that both actors were subject to identical settlement contract conditions. Although Artist Company did not explicitly mention the fellow actor’s name, recent reports noted that former internal director Jung Woo-sung had departed from the company.
Furthermore, the agency clarified that contracts and overseas agency tasks related to ‘Squid Game’ Seasons 2 and 3 were handled by the U.S. agency CAA, and corresponding fees were paid directly to CAA. For other overseas tasks conducted through CAA, separate agency fees were also paid. In contrast, Artist Company received profit distributions under its existing settlement contract despite not directly executing contracts or overseas agency tasks for the said works.
Regarding calculations suggesting the agency could have earned 1.6 billion won more without profit distribution limits, Artist Company criticized the claim as being based on the mere assumption that only the upper limit clause would be removed while all other contract conditions remained unchanged. They emphasized that considering Lee Jung-jae contributes the most to the company’s sales and profits among all affiliated actors, the upper limit clause alone cannot be deemed preferential treatment.
Addressing allegations concerning duplicate office rentals following the acquisition of Ramongraine in a building owned by Lee Jung-jae, the agency explained that existing directors and auditors failed to submit resignation letters as agreed upon in the stock purchase agreement, which caused disruptions in business acquisition and handover. Consequently, the agency filed a damage suit against the former major shareholder and inevitably secured a separate office to ensure normal business activities.
Artist Company also addressed contracts related to the cosmetics brand Vena Beauty, emphasizing that the arrangement was carefully designed to prioritize the company’s profitability and sustainability. Concluding the statement, the agency announced plans to review missing opposing facts, data distortions, and defamation elements to take strict legal measures, including requests for corrections, counter-reports, and damage lawsuits.



